Introduction
The role of ionized Ca2' as a second messenger in a wide variety of cells, including human PMN, is well established. In human PMN transient increases in intracellular ionized calcium concentration ([Ca2+] i)' occur rapidly in response to activation by a variety of soluble as well as particulate stimuli (1, 2) . In response to some stimuli, increased [Ca2+]i appears to be essential, as inhibition ofincreases in [Ca2+]i blocks superoxide PS, phosphatidylserine.
anion production and exocytosis (1) . Furthermore, secretion of granule contents as well as production of superoxide anion can be induced using Ca2" ionophores (3) . Finally, a role for Ca2" in phagosome-lysosome fusion in PMN is suggested by the finding that when these cells ingest opsonized particles, the highest ionized Ca2" concentration is in the periphagosomal region (2) , where granule membranes fuse with the phagosome membrane.
Despite the evidence that Ca2+ is necessary for certain responses in PMN, the proteins that serve as Ca2+-modulated cellular effectors have not been clearly identified. In other systems, recent efforts to identify intracellular proteins that mediate the effects of Ca2' have led to the identification of a family of proteins, the annexins (4) . All of the annexins bind to membrane phospholipids in the presence of Ca2+, and are structurally related: all contain four or eight repeats of a 70-amino acid sequence that is believed to represent the Ca2+-and phospholipid-binding domain. While all nucleated mammalian cells appear to contain at least one annexin protein, the number present and the abundance of individual annexins varies widely in different cell types.
In a first step toward understanding the mechanism of Ca2+-modulated events in human PMN, we examined these cells for proteins that bound reversibly to membrane phospholipids in a Ca2+-dependent manner. This technique yielded several proteins, including small quantities of synexin (5) , as well as an abundant protein with a molecular mass of 33 kD. We describe purification of this protein and characterization of it as a member of the annexin family. This protein is especially abundant in PMN, in contrast to other cells and tissues that have been examined.
Methods
Preparation ofhuman PMN. PMN were isolated and purified (> 97%) from venous blood of normal human volunteers by the method of B6yum (6), using Hypaque-Ficoll gradients and dextran sedimentation. Representative cell suspensions contained < I platelet per 10 PMN. Human PMN cytosol and specific granules were prepared exactly as described previously (5), after sonicating cells in the presence of diisopropylfluorophosphate, leupeptin, pepstatin, and EDTA.
Purification ofCa2'-dependent, phospholipid-binding proteins. Soluble proteins in PMN cytosol were subjected first to precipitation with ammonium sulfate added to 25% saturation (to precipitate synexin) (5) . Proteins in the supernatant were then precipitated by the further addition of solid ammonium sulfate to 95% saturation. Precipitated proteins were suspended in, and dialyzed against, 0.3 M NaCl, 0.1 M TES (N-Tris[hydroxymethyl]methyl-2-aminoethanesulfonic acid), pH mM Ca2", then with the same buffer containing 2.5 mM EGTA (instead of Ca2+). Eluted proteins were dialyzed against either 20 mM sodium acetate, pH 5.0, containing 0.5 mM EDTA (for ion-exchange chromatography on Mono S) or 20 mM bis-tris-propane, pH 6.8 (for chromatography on Mono Q). Samples were applied to the designated column in an FPLC system (Pharmacia Fine Chemicals, Piscataway, NJ) operated at room temperature, and were eluted with a linear gradient of NaCl in the appropriate buffer.
Lipocortins I and III, calpactin I, endonexin II, p68, and protein II were purified from human placenta using a modification of the procedure of Haigler et al. (7, 8) .
Electrophoresis. One-dimensional SDS-PAGE was performed using the Laemmli buffer system (9), and two-dimensional PAGE was performed by the method of O'Farrell (10) .
Calcium-dependent binding to phospholipid vesicles. All components in the assay were prepared in 0. 
were prepared and characterized as described in detail elsewhere (8 (6. 25 X 107/ml) containing 2 mM disopropylfluorophosphate, 1 mM PMSF, 5 mM EDTA, and 1% Triton X-100. After centrifugation (1,000 g, 5 min) to pellet nuclei, the lysate supernatants were diluted with 4X Laemmli sample buffer to 5 X 107 cell equivalents/ml. Serial twofold dilutions were prepared in sample buffer such that 20 ul represented from 2.5 X 105 to 7.8 X 103 cell equivalents, and these dilutions from the cells of two donors were subjected to SDS-PAGE and Western blotting.
Western blotting. Western blotting was performed essentially as described by Burnette ( 12) . Bound antibodies were detected using biotinylated goat anti-rabbit Ig followed by streptavidin-alkaline phosphatase, with 5-bromo-4-chloro-3-indolyl phosphate and nitroblue tetrazolium as substrates. For quantitative Western blotting, membranes were subsequently treated with affinity-purified rabbit anti-goat Ig (0.5 Ag/ml) ( (Fig. 1 A) . Two-dimensional PAGE on the same samples revealed the presence of one predominant protein spot at each of these molecular masses, as well as one (36 kD) or two (33 kD) minor protein spots (Fig. 1 B) . Similar The major 33-kD protein was purified to apparent homogeneity by subsequent ion-exchange chromatography (Fig. 2) . Since no unique activity could be attributed to this protein during purification, recovery ofthe protein was not calculated. However, as detailed in Table I , the purification procedure described yielded 35 ,ug of electrophoretically pure 33-kD protein, beginning with cytosol from l-0 PMN.
To determine whether the protein we purified bound directly to phospholipids in a Ca2+-dependent manner (rather than to another protein that bound to phospholipids on the column), we examined whether the purified 33-kD PMN protein bound to PS, using a simple centrifugation assay. As shown in Fig. 3 the purified protein bound to pure PS vesicles in the presence of micromolar concentrations ofCa2+, while it eluted from the liposome column at 0.1 mM Ca2 , initially appeared contradictory. However, we have subsequently determined that the presence of PC significantly increases the Ca2' requirement for binding ofthe 33-kD PMN protein (and other annexins) to PS (Blackwood, R. A., and J. D. Ernst, manuscript in preparation). Therefore, the purified 33-kD PMN protein binds directly to pure PS in the presence of low micromolar concentrations of Ca2 , while the presence of PC in the liposomes used for affinity purification facilitates elution of the protein from the affinity matrix (at 0.1 mM Ca2+).
In addition to sharing the property of Ca2+-dependent binding to phospholipids, members of the annexin family also share structural similarities. The most prominent of these is a highly conserved 17-amino acid sequence that is present in at least four copies per protein. To determine whether this sequence motif is present in the 33-kD PMN protein, we examined it by Western blotting, using polyclonal antiserum directed against a 17-amino acid synthetic peptide resembling the consensus sequence present in annexins. As shown in Fig.  4 , this antiserum specifically recognized the 33-kD PMN protein, and recognition was blocked by preincubation of the antiserum with the synthetic peptide. Therefore, the PMN 33-kD protein is similar antigenically to other members of the annexin family.
Further similarity between the 33-kD PMN protein and other members of the annexin family was sought by obtaining amino acid sequence from the purified protein. Initial attempts at determining NH2-terminal sequence from the intact protein were unsuccessful, as it was found to have a blocked amino terminus. Therefore, 100 Mg (-3 nmol) of purified protein was cleaved either with CNBr or with lysyl-endopeptidase, and sequence was determined from a total of nine peptides purified by reverse-phase chromatography. As shown in Fig. 5 , unambiguous sequence was determined for a total of 115 amino acids: over one-third of the predicted total, based on the electrophoretic mobility of the protein. Also shown in Fig. 5 is comparison ofthe determined amino acid sequence of the fragments from the purified PMN 33-kD protein with the sequence predicted from the cDNA sequence of human lipocortin III (14) . All of the residues determined from fragments of the purified 33-kD protein from human PMN correspond to amino acids predicted from the lipocortin III cDNA. Therefore, the protein we have purified is likely to be identical to lipocortin III, which was recently described as an apparent inhibitor of phospholipase A2.
One property predicted for a membrane-binding protein that might mediate fusion of membranes ofphagocytic vesicles and neutrophil granules is that of synexin-like activity, i.e., the ability to crosslink membranes, manifested as aggregation of vesicles. Fig. 6 demonstrates that the purified PMN 33-kD protein (lipocortin III) can promote Ca2+-dependent aggregation of isolated human PMN specific granules. Under the conditions of the assay, this activity required high concentrations of Ca2+: 1 mM led to the maximal apparent rate and extent of granule aggregation. Addition of Ca2+ to a final concentration of 0.5 mM caused changes in absorbance of -50% of the magnitude shown in Fig. 6 , whereas addition of Ca2`to 2 mM gave results indistinguishable in rate and magnitude from those shown. Addition ofMg2' (1 mM) did not substitute for, potentiate, or inhibit the effects of 500 MM or 1 mM Ca2 . Addition of purified protein to 20 ,g/ml gave results indistinguishable from those presented, which were obtained using 10 ,Mg/ml. In control experiments, no change in absorbance was observed when the purified protein, granules, or Ca2+ were omitted. Addition of BSA as a control protein did not cause changes in absorbance, and dilute suspensions of Percoll (which can contaminate these granule preparations) did not A polyclonal antiserum was prepared by immunizing rabbits with human lipocortin III purified from placenta. This antiserum, when used at a 1:10,000 dilution, recognized as little as 1.6 ng of purified lipocortin III on Western blots. Furthermore, it recognized a single protein band (with the expected electrophoretic mobility} in detergent lysates of human PMN (Fig. 7) . Preimmune serum from the same rabbit did not give any detectable reaction with blotted PMN proteins. Since two other annexins with similar molecular weights have been described, we examined the ability ofthis antiserum to recognize human endonexin II and human protein II (also known as human placental anticoagulant protein IV [15] or PP4-X [16] ) purified from human placenta. When these proteins (up to 100 ng/lane) were examined on Western blots with this antiserum at a 1:10,000 dilution, no reactivity above background was detected. Therefore, the 33-kD band detected in lysates of PMN clearly represents the protein used to raise this antiserum.
This specific antiserum was used to determine that lipocortin III is a highly abundant protein in human PMN. Using a solid-phase Western blot immunoassay, we found that PMN contain 328±56 ng lipocortin III/ 106 cells (mean±SD; n = 12).
As human PMN contain -30 ,g of cytosol protein/ 106 cells of their cytosolic protein.
Finally, we used this antiserum to examine the distribution of the 33-kD PMN protein by indirect immunofluorescence (Fig. 8) . The intracellular location of the protein was established by the lack of fluorescence of cells that were not permeabilized (not shown), and a cytosolic distribution of the protein was indicated by a reticular pattern of fluorescence that did not correspond to any obvious intracellular structure. This finding is consistent with our finding that the 33-kD protein is found in the cytosol fraction after disruption of PMN by sonication.
Discussion
In an effort to further define the pathways determining responses of human PMN to stimuli that increase [Ca2+]i, we examined the cytosol of these cells for proteins that bound to membrane phospholipids in a Ca2l-dependent manner. We found that these cells possess several proteins that exhibit this property. We characterized the most abundant of these, and found that it is identical to lipocortin III, a member of the annexin family that is scarce in most cells and tissues examined to date. We have determined that this protein represents Figure 8 . Indirect immunofluorescence using the polyclonal anti-lipocortin III antiserum (as shown in Fig. 7 (18) presents evidence that another member of the annexin family, calpactin I, causes aggregation of isolated adrenal chromaffin granules at concentrations of Ca2" that are more nearly physiologic than those used in this study. However, there are many differences between the results in that report and those reported here. First, chromaffin granules are much more uniform in size, shape, and light scattering properties than PMN specific granules. This presents a more favorable signal-to-noise relationship in the assay, which permits the detection of very small changes in absorbance. Second, that study showed that while detectable aggregation of chromaffin granules occurred in the presence of micromolar concentrations of ionized calcium, aggregation was greater in both rate and extent when higher calcium concentrations (1 mM) were used. Moreover, the assay used in that study is performed at lower ionic strength (30 mM KCl, 40 mM Hepes, remainder of osmoles as sucrose). For these reasons it is difficult to directly compare the Ca2" concentrations required in these two systems; however, it is possible that these two related proteins require different concentrations of Ca2" to exhibit granule-aggregating activity.
The same protein (lipocortin III) that we describe from human PMN has recently been described as possessing two other activities. It has been characterized as a lipocortin, in that it can inhibit the activity of phospholipase A2 in an in vitro assay (14) , and it has also been recently characterized as an inhibitor of blood coagulation ( 15) . Both of these activities appear to be a consequence of Ca2l-dependent phospholipid binding (7, 19, 20) , as these reactions require access of the active enzymes to phospholipids, which act as substrates (for phospholipase A2) or cofactors (for clotting Factors Xa and Va). Our finding that lipocortin III (also termed placental anticoagulant protein III [ 15] ) can promote aggregation of isolated PMN specific granules suggests a positive rather than negative regulatory role for this protein. However, further work is necessary to firmly establish a clear intracellular function for this and other annexins.
The predominance of lipocortin III among the 32-33-kD annexins in human PMN is in contrast to its scarcity (compared with protein II and endonexin II) in human placenta (7, 15) and spleen, and its apparent absence from human liver (Ernst, J. D., and E. Hoye, unpublished observations). Indeed, the relative scarcity and/or restricted distribution of this protein is reflected in the fact that it is the most recent of the annexins to be described (14, 15) . Further studies of the cellular location of this protein in the tissues in which it is found will be necessary before firm statements can be made regarding the nature of its distribution; nevertheless, we find that it isespecially abundant in human PMN.
The abundance of this protein, together with its ability to reversibly associate with membranes in a Ca2+-dependent manner as well as to promote granule-granule aggregation, makes it a candidate modulator of membrane-localized, Ca2+-modulated events such as phagosome-lysosome fusion in human PMN. Further work to define the potential role of this protein in either exocytosis or phagosome-lysosome fusion in PMN is currently in progress.
